---
_schema: default
id: 55960
date: 2024-11-27
title: >-
    What are the clinical descriptions of sedative-, hypnotic-, and anxiolytic-related disorders?
article_title: >-
    What are the clinical descriptions of sedative-, hypnotic-, and anxiolytic-related disorders?
date_format: MMM DD, YYYY
post_on_text: Posted on
seo:
  title: QuickTakes | Health Studies
  page_description: >-
    Sedative-, hypnotic-, and anxiolytic-related disorders are substance use disorders characterized by the troubling use of CNS depressants, leading to significant impairment and various symptoms such as mood changes and coordination problems.
  page_keywords: >-
    sedative disorders,hypnotic disorders,anxiolytic disorders,substance use disorder,substance misuse,benzodiazepines,Z-drugs,GABA,depressant effects,intoxication,withdrawal,clinical symptoms,mental health,DSM-5-TR
author: QuickTakes
question: >-
    What are the clinical descriptions of sedative-, hypnotic-, and anxiolytic-related disorders?
answer: >-
    Sedative-, hypnotic-, and anxiolytic-related disorders are classified as substance use disorders characterized by the problematic use of substances that depress the central nervous system. According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), the diagnosis of a sedative, hypnotic, or anxiolytic use disorder requires clinically significant impairment or distress over a 12-month period, along with the presence of at least two out of eleven specific criteria.\n\n### Clinical Descriptions\n\n1. **Substance Use Pattern**: The disorder is defined by a pattern of use that results in clinically significant harm to the individual's physical or mental health, or that causes harm to others due to behaviors induced by these substances.\n\n2. **Common Substances**: The most frequently misused medications in this category include benzodiazepines (often referred to as "benzos," "downers," or "nerve pills") and Z-drugs (e.g., zolpidem, zaleplon). These substances enhance the effects of the neurotransmitter GABA in the brain, leading to a depressant effect on neurotransmission levels.\n\n3. **Symptoms**: Symptoms of sedative, hypnotic, or anxiolytic use disorder can manifest as behavioral and psychological changes that impede daily functioning and cause significant distress. Acute intoxication may present with:\n   - Mood changes\n   - Slowed breathing\n   - Tiredness\n   - Slurred speech\n   - Coordination problems\n   - Memory difficulties\n   - In severe cases, stupor or coma\n\n4. **Consequences**: The consequences of this disorder can include decreased work performance, reduced motivation for social interactions or activities, and impaired ability to drive or operate machinery safely.\n\n5. **Withdrawal and Intoxication**: The DSM-5-TR also provides diagnostic criteria for acute intoxication and withdrawal from these substances, which can further complicate the clinical picture.\n\nIn summary, sedative-, hypnotic-, and anxiolytic-related disorders are serious conditions that require careful diagnosis and management due to their potential for significant impairment in various aspects of life.
subject: Health Studies
file_name: what-are-the-clinical-descriptions-of-sedative-hypnotic-and-anxiolyticrelated-disorders.md
url: /learn/health-studies/questions/what-are-the-clinical-descriptions-of-sedative-hypnotic-and-anxiolyticrelated-disorders
score: -1.0
related_article1:
    id: 55955
    title: >-
        What are the clinical descriptions of alcohol-related disorders?
    subject: Health Studies
    url: /learn/health-studies/questions/what-are-the-clinical-descriptions-of-alcoholrelated-disorders
---

&nbsp;